Eli Lilly and ROE 2024

Eli Lilly and ROE

0.49

Eli Lilly and Dividend yield

0.58 %

Ticker

LLY

ISIN

US5324571083

WKN

858560

In 2024, Eli Lilly and's return on equity (ROE) was 0.49, a -17.04% increase from the 0.59 ROE in the previous year.

Eli Lilly and Aktienanalyse

What does Eli Lilly and do?

Eli Lilly and Co. is a global biopharmaceutical company headquartered in Indianapolis, Indiana, USA. The company was founded in 1876 by Colonel Eli Lilly with the aim of manufacturing pharmaceutical products of the highest quality. Eli Lilly began his career in the pharmacy industry and opened his own pharmacy in Indianapolis in 1876. He quickly developed his own medications and eventually established Eli Lilly and Company in 1901. Over the years, the company has continued to evolve and expand its business into numerous areas. Eli Lilly is focused on biopharmaceutical research and development and operates in areas such as oncology, diabetes, neurology, and others. The company's main goal is to develop drugs that can change and improve lives. Eli Lilly invests a high percentage of its revenue into research and development every year. The company has several strategic business units, including human pharmaceuticals, animal pharmaceuticals, and oncology research. Eli Lilly is divided into five main divisions: diabetes, oncology, immunology, neurology, and animal health. The diabetes division focuses on manufacturing insulin products and glucose sensors for the treatment of type 1 and type 2 diabetes, as well as blood glucose meters and other diabetes products. The oncology division focuses on researching and developing drugs to treat cancer. The company currently has several compounds in clinical trials, including a new preparation for the treatment of breast cancer. The immunology division focuses on products for the treatment of autoimmune and inflammatory diseases, such as psoriasis. The neurology division focuses on researching and developing drugs to treat diseases of the nervous system, such as Alzheimer's. The animal health division focuses on animal health products, such as drugs for the treatment of infections in livestock and pets. Eli Lilly is primarily known for its insulin products and treatments in the field of oncology. Some of the company's most well-known products include Humalog, Forteo, Alimta, and Cymbalta. The effectiveness and compliance of the products are monitored by a quality and safety system to ensure that patients receive the highest quality medications. In conclusion, Eli Lilly and Co. is a company with a long history and a unique business model. The company specializes in developing high-quality pharmaceutical products and has continued to evolve since its founding. Eli Lilly has become a leader in various areas such as diabetes, oncology, immunology, neurology, and animal health. They are known for their insulin products and treatments in the field of oncology. The company remains committed to expanding its reach and presence globally and continues to develop innovative products that can improve and change people's lives. Eli Lilly and ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Eli Lilly and's Return on Equity (ROE)

Eli Lilly and's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Eli Lilly and's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Eli Lilly and's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Eli Lilly and’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Eli Lilly and Stock

What is the ROE (Return on Equity) of Eli Lilly and this year?

The ROE of Eli Lilly and this year is 0.49 undefined.

How has the Return on Equity (ROE) of Eli Lilly and developed compared to the previous year?

The ROE of Eli Lilly and has increased by -17.04% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Eli Lilly and?

A high ROE indicates that Eli Lilly and generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Eli Lilly and?

A low ROE can indicate that Eli Lilly and is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Eli Lilly and affect the company?

A change in ROE (Return on Equity) of Eli Lilly and can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Eli Lilly and?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Eli Lilly and?

Some factors that can influence Eli Lilly and's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Eli Lilly and pay?

Over the past 12 months, Eli Lilly and paid a dividend of 4.52 USD . This corresponds to a dividend yield of about 0.58 %. For the coming 12 months, Eli Lilly and is expected to pay a dividend of 5.73 USD.

What is the dividend yield of Eli Lilly and?

The current dividend yield of Eli Lilly and is 0.58 %.

When does Eli Lilly and pay dividends?

Eli Lilly and pays a quarterly dividend. This is distributed in the months of June, September, December, March.

How secure is the dividend of Eli Lilly and?

Eli Lilly and paid dividends every year for the past 26 years.

What is the dividend of Eli Lilly and?

For the upcoming 12 months, dividends amounting to 5.73 USD are expected. This corresponds to a dividend yield of 0.74 %.

In which sector is Eli Lilly and located?

Eli Lilly and is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eli Lilly and kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eli Lilly and from 3/8/2024 amounting to 1.3 USD, you needed to have the stock in your portfolio before the ex-date on 2/14/2024.

When did Eli Lilly and pay the last dividend?

The last dividend was paid out on 3/8/2024.

What was the dividend of Eli Lilly and in the year 2023?

In the year 2023, Eli Lilly and distributed 3.92 USD as dividends.

In which currency does Eli Lilly and pay out the dividend?

The dividends of Eli Lilly and are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eli Lilly and stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Eli Lilly and

Our stock analysis for Eli Lilly and Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eli Lilly and Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.